Simpson Thacher recently represented Broad Street Principal Investments, L.L.C., an affiliate of Goldman Sachs & Co., in connection with the financing for its acquisition of Ebix, Inc. (EBIX), a public company listed on the NASDAQ Global Market. The transaction, which is expected to close later this year, values Ebix, Inc., at about $820 million. Ebix, Inc. is a leading international supplier of software and e-commerce solutions to the insurance industry.

More >>

The Firm recently represented Cogeco Cable Inc. (“Cogeco Cable”) in its offering of $400 million aggregate principal amount of 4.875% Senior Notes due 2020. Cogeco Cable is using the net proceeds from the offering, together with borrowings under its revolving credit facility, to repay in full the term loan tranches of the senior secured credit facilities entered into in connection with its acquisition of PEER 1 Network Enterprises, Inc. in January 2013. The notes are guaranteed by certain of Cogeco Cable’s wholly-owned subsidiaries. The offering was conducted in reliance on Rule 144A and Regulation S.

More >>

Simpson Thacher represented the initial purchasers, led by joint book-running managers, J.P. Morgan Securities LLC and Goldman, Sachs & Co., and by co-managers, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Wells Fargo Securities, LLC, BB&T Capital Markets, a division of BB&T Securities, LLC and Citigroup Global Markets Inc., in the sale of an aggregate principal amount of $250 million 4.75% Senior Notes due 2021 by Rent-A-Center, Inc. (“Rent-A-Center”). The notes are guaranteed on an unsecured senior basis by each of Rent-A-Center’s existing and future subsidiaries that are either borrowers under Rent-A-Center’s senior credit facilities or that guarantee any indebtedness of Rent-A-Center or any other guarantor, subject to certain exceptions. Rent-A-Center intends to use the net proceeds from the offering to (1) repay $46 million of the revolving loans outstanding under its revolving credit facility and (2) apply the remainder to accelerated common stock repurchases as market conditions permit, and to the extent not so applied, for general corporate purposes.

More >>

The Firm is representing Melrose Industries PLC (“Melrose”) in connection with its announced sale of Truth Hardware (“Truth”) to Tyman PLC. The total consideration for this transaction is US$200 million (£129 million), and will be payable in cash upon completion. Melrose intends to use the proceeds to pay down existing borrowings. The transaction is expected to close in June 2013.

More >>

McKenna Long & Aldridge LLP (MLA) today announced that Craig M. Johnson, former New York State Senator, has joined its national Government Affairs practice as Managing Director effective May 20, 2013. He will operate out of the firm’s New York, New York and Albany, New York offices.

More >>

Paul Hastings, a leading global law firm, announced today that the firm represented RBC Capital Markets in connection with the issuance of first lien and second lien loans to Healogics, Inc., the nation’s largest provider of advanced wound care services, in connection with the refinancing of the Borrower’s existing indebtedness.

More >>

Paul Hastings, a leading global law firm, announced today that the firm represented RBC Capital Markets and Merrill Lynch, Pierce, Fenner & Smith Incorporated as Joint Lead Arrangers and RBC Capital Markets, Merrill Lynch, Pierce, Fenner & Smith Incorporated and GE Capital Markets, Inc. as Joint Bookrunners in connection with a $330 million term loan and a $50 million revolving loan to Micro Holding, L.P. and Internet Brands, Inc.

More >>

Sullivan & Worcester LLP is pleased to announce that Harry H. Rimm has joined the Litigation Group as a partner in the New York office. Mr. Rimm has significant experience defending corporations in complex civil litigation in numerous federal and state jurisdictions and handling corporate investigations and white-collar criminal matters.

More >>

Leading international law firm Clifford Chance today announced that Emily DiStefano has joined the firm as an Asset Finance partner in New York, further bolstering one of the world’s leading aviation finance practices.

More >>

On April 29, it was announced that Willkie client Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, has completed its acquisition of private urology specialty therapeutics company Actient Holdings LLC. Auxilium is paying $585 million in upfront cash plus certain contingent consideration and warrants to purchase Auxilium common stock, for a total enterprise value of up to $657 million. Based in Lake Forest, IL, Actient’s urology portfolio includes TESTOPEL, the only long-acting implantable testosterone replacement therapy (TRT) and Edex, the leading branded non-oral drug for erectile dysfunction. Chesterbrook, PA-based Auxilium focuses on developing and marketing products, including Testim 1% (testosterone gel) in the U.S. for the topical treatment of hypogonadism, to predominantly specialist audiences. The deal is expected to create a leading urology platform with the widest range of products for TRT.

More >>